Diabetes care in the dispersed population of Greenland. A new model based on continued monitoring, analysis and adjustment of initiatives taken

Pedersen, Michael Lynge

doi:10.1080/22423982.2019.1709257

Cited by 28 publications

(33 citation statements)

References 181 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The study was performed as a cross-sectional study using data from the electronical medical record (EMR) [ 14 ] in Greenland.…”

Section: Methodsmentioning

confidence: 99%

“…Even though Greenland is the largest island in the world, covering an area of more than 2 million km 2 , most of the area is uninhabited because of the icecap [ 14 ]. The population thus lives along the coastline, distributed in 17 towns and approximately 60 minor settlements [ 15 ].…”

Section: Methodsmentioning

confidence: 99%

“…Since 2014, all consultations, including the hospital, health care centre and settlement consultation, have been registered in the same EMR [ 6 , 14 ].…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Prevalence and quality of care among patients using medication targeting obstructive lung disease: a cross-sectional study in the five regions of Greenland

Lauridsen

Backe

Bonefeld-Jörgensen

et al. 2021

International Journal of Circumpolar Health

Self Cite

View full text Add to dashboard Cite

The aim of this study was to estimate the age-and gender-specific prevalence and quality of care among patients using medication targeting obstructive lung disease in the five regions of Greenland. The study was designed as a cross-sectional study. Data on patients using medication targeting obstructive lung disease was obtained from the electronically medical record used in Greenland. The prevalence was calculated using the population of Greenland as background population. The quality of care was determined using indicators proposed by international literature and the Steno Diabetes Center Greenland guidelines. The total prevalence of patients using medication targeting obstructive lung disease was 7.5%. The prevalence was significantly higher among women compared to men and differed significantly between the five regions. Smoking status, blood pressure and spirometry were registered within one/two years for 29.8%/ 43.2%, 29.2%/41.1% and 15.9%/26.0% of the patients, respectively. Regional differences were observed for all indicators.The use of medication targeting obstructive lung disease is common in Greenland. Yet, the quality of care was low and interventions improving the quality of care is recommended.

show abstract

“…The study was performed as a cross-sectional study using data from the electronical medical record (EMR) [ 14 ] in Greenland.…”

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence and quality of care among patients using medication targeting obstructive lung disease: a cross-sectional study in the five regions of Greenland

Lauridsen

Backe

Bonefeld-Jörgensen

et al. 2021

International Journal of Circumpolar Health

Self Cite

View full text Add to dashboard Cite

show abstract

“…The study was performed as a cross-sectional study, using data from population and medical registers in Greenland [15,16] and Denmark [17,18].…”

Section: Methodsmentioning

confidence: 99%

Prevalence of patients treated with antidepressant medicine in Greenland and Denmark: a cross-sectional study

Ingemann

Backe

Bonefeld-Jörgensen

et al. 2021

International Journal of Circumpolar Health

Self Cite

View full text Add to dashboard Cite

Depression is a mental illness affecting more than 260 million people worldwide. In Greenland, the prevalence of patients treated with antidepressant medicine (antidepressants) has not previously been investigated. The aim of this study was to estimate and compare the age-and gender-specific prevalence of patients treated with antidepressants in Greenland and Denmark. The study was a cross-sectional register study using data from population and medical registers in Greenland and Denmark. Included was 1,573 Greenlandic patients and 419,151 Danish patients treated with antidepressants, respectively. The overall prevalence of patients aged 10-89 years treated with antidepressants was 3.5% in Greenland, and 8.1% in Denmark, being significantly lower in Greenland compared to Denmark (p < 0.001). The age-and gender-specific prevalence was significantly lower for patients from Greenland compared to from Denmark. In both Greenland and Denmark, the prevalence of women receiving antidepressants was significantly higher than for men. Finally, there was regional differences in the prevalence of usage of antidepressants in Greenland. Undiagnosed depression might contribute to the lower prevalence in Greenland as well as limited access to primary healthcare.

show abstract

“…Approximately 15 years after the beginning of DM, diabetic nephropathy develops in 20% to 30% of patients [3,4]. In 2017, the international diabetes federation estimated that 425 million adults between 20 and 79 have diabetes, corresponding to an 8.8% prevalence of diabetes globally [5]. CKD is de ned as abnormalities of kidney function or structure or an estimated GFR <60 mL/min per 1.73 m2 present for >3 months [6].…”

Section: Introductionmentioning

confidence: 99%

“Evaluation of Anti-Inflammatory Effects of Allopurinol in Diabetic Patients with Chronic Kidney Disease (DM-CKD): A Clinical Study”

Daniyali

Mahmoudieh

Afzal

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: Diabetic nephropathy is the most prevalent cause of end-stage kidney disease (ESRD). Besides, factors such as; pro-fibrotic, cytokines, vascular endothelial growth factor, inflammatory factor, and uric acid may play a role in creating and progressing diabetic nephropathy. Decreasing the serum level of inflammatory factors can be useful in the treatment of diabetic nephropathy. Therefore, this study aimed to evaluate allopurinol's anti-inflammatory effects in diabetic patients with chronic kidney disease.Methods: In this clinical trial, 60 diabetic patients with chronic kidney disease and normal uric acid level were enrolled into the study with certain inclusion and exclusion criteria. Patients received allopurinol at a dose of 100 mg daily. Demographic parameters, laboratory results in blood urea nitrogen (BUN), serum creatinine (sCr), glomerular filtration rate (GFR), 24-hour urine protein (PrUrine24h), uric acid, serum albumin (Alb), systolic blood pressure (SBP), diastolic blood pressure (DBP), glycosylated hemoglobin (HbA1C) and high sensitivity C reactive protein (HSCRP), as well as adverse reactions, were recorded at baseline, ones and three months after.Results: The results showed that patients were not different in point of demographic parameters at baseline. Laboratory results such as; BUN, sCr, GFR, PrUrine24h, Alb, SBP, DBP, and HbA1C did not change significantly over study duration (P>0.05), except uric acid and HSCRP, which were significantly decreased in patients (P=0.024 and P=0.016, respectively). There was not any notable adverse reaction among patients.Conclusion: Low dose Allopurinol (100 mg/day) reduced uric acid and inflammatory biomarker (HSCRP) after three administration months. According to the present study results, Allopurinol can be considered an auxiliary, inexpensive, and low side-effect therapy in diabetic patients with chronic kidney disease.

show abstract

Diabetes care in the dispersed population of Greenland. A new model based on continued monitoring, analysis and adjustment of initiatives taken

Abstract: View related articlesView Crossmark data Citing articles: 3 View citing articlesDiabetes care in the dispersed population of Greenland. A new model based on continued monitoring, analysis and adjustment of initiatives taken

Cited by 28 publications

References 181 publications

Prevalence and quality of care among patients using medication targeting obstructive lung disease: a cross-sectional study in the five regions of Greenland

Prevalence and quality of care among patients using medication targeting obstructive lung disease: a cross-sectional study in the five regions of Greenland

Prevalence of patients treated with antidepressant medicine in Greenland and Denmark: a cross-sectional study

“Evaluation of Anti-Inflammatory Effects of Allopurinol in Diabetic Patients with Chronic Kidney Disease (DM-CKD): A Clinical Study”

Contact Info

Product

Resources

About